Results 231 to 240 of about 101,135 (306)
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis
Immunosuppressive disease was associated with reduced overall survival, while anticoagulant use was linked to prolonged progression‐free survival in advanced cutaneous squamous cell carcinoma treated with immune checkpoint inhibitors. Host‐related factors may modulate immunotherapy efficacy and warrant prospective validation.
Glenn Geidel +27 more
wiley +1 more source
Case Report: Methanol poisoning mimicking acute coronary syndrome-a fatal case of massive intracranial hemorrhage on dual antiplatelet therapy. [PDF]
Zhu J, Wei P, Wang Y, Yang X.
europepmc +1 more source
ABSTRACT Background Evidence guiding first‐line antihypertensive drug choice in adults aged 75 years or older is limited, despite widespread use of angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) in late older age. Methods We conducted a target trial emulation using a new‐user design in a nationwide linked healthcare claims ...
Hisashi Noma +6 more
wiley +1 more source
ABSTRACT Objective This study aimed to investigate the self‐reported confidence levels of final year dental students at the University of Queensland, Australia, in oral surgery procedures and general medicine to locate gaps in knowledge and aid in improving the dental curriculum.
Hsin‐Chen Lee +4 more
wiley +1 more source
Impact of antiplatelet therapy on the hemostatic efficacy of platelet-targeted FVIII gene therapy in hemophilia A mice. [PDF]
Yu H +4 more
europepmc +1 more source
Seeking for the boundaries of de-escalation in antiplatelet therapy for acute coronary syndrome. [PDF]
Galli M, Gragnano F, Valgimigli M.
europepmc +1 more source
Witnessing a possible revolution in antiplatelet therapy for coronary artery bypass grafting. [PDF]
Galli M, Gragnano F, Gaudino M.
europepmc +1 more source
Direct Oral Anticoagulant Monotherapy Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: A Meta-Analysis of Randomized Trials. [PDF]
Ammirabile N +4 more
europepmc +1 more source

